Reid ME, Lomas-Francis C.The blood group antigen factsbook. Academic Press, Inc., San Diego, CA : 1997.Search in Google Scholar
Goldstein J. Conversion of ABO blood groups. Transfus Med Rev 1989;3:206–12.10.1016/S0887-7963(89)70080-8Search in Google Scholar
Lenny LL, Hurst R, Zhu A, Goldstein J, Galbraith RA. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials. Transfusion 1995;35:899–902.10.1046/j.1537-2995.1995.351196110892.xSearch in Google Scholar
Lenny LL, Hurst R, Goldstein J, Galbraith RA. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.Transfusion 1994;34:209–14.10.1046/j.1537-2995.1994.34394196617.xSearch in Google Scholar
Veronese FM, Morpurgo M. Bioconjugation in pharmaceutical chemistry. Farmaco 1999;54:497–516.10.1016/S0014-827X(99)00066-XSearch in Google Scholar
Delgado C, Francis GE, Fisher D.The uses and properties of PEG-linked proteins. Crit Rev Ther Drug Carrier Syst 1992;9:249–304.Search in Google Scholar
Gribben JG, D evereux S, Thomas NS, et al. Development of antibodies to unprotected glycosylation sites on recombinant human GM–CSF. Lancet 1990;335:434–7.10.1016/0140-6736(90)90665-RSearch in Google Scholar
Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 1977;252:3578–81.10.1016/S0021-9258(17)40291-2Search in Google Scholar
Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977;252:3582–6.10.1016/S0021-9258(17)40292-4Search in Google Scholar
Hershfield MS, Buckley RH, Greenberg ML, et al. Treatment of adenosine deaminase deficiency with polyethylene glycol modified adenosine deaminase. N Engl J Med 1987;316:589–96.10.1056/NEJM198703053161005Search in Google Scholar
Hershfield MS. PEG–ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin Immunol Immunopathol 1995;76: S228–32.10.1016/S0090-1229(95)90306-2Search in Google Scholar
Keating MJ, Holmes R, Lerner S, Ho DH. L-asparaginase and PEG asparaginase—past, present, and future (abstract). Leuk Lymphoma 1993;10(Suppl): 153–7.10.3109/104281993091491298481665Search in Google Scholar
Holle LM. Pegaspargase: an alternative? Ann Pharmacother 1997;31(5):616–24.10.1177/106002809703100517Search in Google Scholar
Malik F, Delgado C, Knusli C, Irvine AE, Fisher D, Francis GE.Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM–CSF) with conserved biological activity. Exp Hematol 1992;20:1028–35.Search in Google Scholar
Conover CD, Gi lbert CW, Shum KL, Shorr RG. The impact of polyethylene glycol conjugation on bovine hemoglobin’s circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Artif Organs 1997;21:907–15.10.1111/j.1525-1594.1997.tb00250.xSearch in Google Scholar
Kjellander R, Florin E. Water structure and changes in thermal stability of the system poly(ethylene oxide)-water. J Chem Soc (Faraday Trans 1) 1981;77: 2053–77.10.1039/f19817702053Search in Google Scholar
Harris JM. Poly(ethylene glycol) chemistry:biotechnical and biomedical applications. New York:Plenum Press, 1992.10.1007/978-1-4899-0703-5Search in Google Scholar
Zalipsky S. Chemistry of poly(ethylene glycol) conjugates with biologically active molecules. Adv Drug Delivery Rev 1995; 16:157–82.10.1016/0169-409X(95)00023-ZSearch in Google Scholar
Knoll D, Hermans J. Protein-polymer interactions: comparison of experiment and excluded volume theory. J Biol Chem 1983;258:5710–5.10.1016/S0021-9258(20)81951-6Search in Google Scholar
Atha DH, Ingham KC. Mechanism of precipitation of proteins by polyethylene glycols: analysis in terms of excluded volume. J Biol Chem 1981; 256: 12108–17.10.1016/S0021-9258(18)43240-1Search in Google Scholar
Jeong ST, Byun SM. Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells: significance as a blood substitute. Art Cells Blood Subs Immob Biotech 1996;24:503–11.10.3109/10731199609117442Search in Google Scholar
Armstrong JK, Meiselman HJ, Fisher TC. Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low-shear blood viscosity. Am J Hematol 1997; 56:26–8.10.1002/(SICI)1096-8652(199709)56:1<26::AID-AJH5>3.0.CO;2-4Search in Google Scholar
Scott MD, Murad KL, Koumpouras F, Talbot M, Eaton JW. Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci 1997; 94:7566–71.10.1073/pnas.94.14.7566Search in Google Scholar
Hortin GL, Lok HT, Huang ST. Progress toward preparation of universal donor red cells. Art Cells Blood Subs Immob Biotech 1997;25:487–91.10.3109/10731199709118939Search in Google Scholar
Jeong ST, Byun SM.The decrease of agglutinability of human AB type red blood cells by attachment of methoxy-polyethylene glycol. Art Cells Blood Subs Immob Biotech 1996;24:358.Search in Google Scholar
Scott MD, Murad KL.Cellular camouflage:fooling the immune system with polymers. Curr Pharm Des 1998;4:423–38.10.2174/138161280406221011110509Search in Google Scholar
Murad KL, Mahany KL, Brugnara C, Kuypers FA, Eaton JW, Scott MD. Structural and functional consequences of antigenic modulation of red blood cells with methoxy poly(ethylene glycol). Blood 1999; 93:2121–7.10.1182/blood.V93.6.2121.406a30_2121_2127Search in Google Scholar
M ah any KL, M u rad KL, Scott MD. Attenuated immunogenicity of xenogeneic and heterologous erythrocytes modified with methoxypoly(ethylene glycol) (abstract). Blood 1998; 92(Suppl 1):672a.Search in Google Scholar
Fisher TC, Armstrong JK, Meiselman HJ, Leger RM, Arndt P, Garratty G. Properties of poly(ethylene gly- col)-conjugated red blood cells.In:Blood substitutes, present and future perspectives. Tsuchida E (ed). New York :Elsevier Science, 1998.Search in Google Scholar
Fisher TC, Armstrong JK, Meiselman HJ, Leger RM, Arndt P, Garratty G. Polyethylene glycol coating of red blood cells strongly inhibits agglutination, but does not produce cells that are antigenically”silent” (abstract).Transfusion 1997; 37(Suppl):S350.10.1016/B978-044420524-7/50024-2Search in Google Scholar
Huang ST, Hortin GL, Huang Z. Coating of red blood cells with crosslinked polyethylene glycol (XPEG) inhibits agglutination and shows favorable red cell survival (abstract).Transfusion 1998;38 (Suppl):S227.Search in Google Scholar
Monfardini C, Schiavon O, Caliceti P, Morpurgo M, Harris JM, Veronese FM. A branched monometh-oxy(polyethylene glycol) for protein modification. Bioconj Chem 1995;6:62–9.10.1021/bc00031a006Search in Google Scholar
Huang ST, Huang Z, Marques MB, Prchal JT. Adding methoxy polyethylene glycol to red blood cells coated with crosslinked polyethylene glycol-albu- min prevents reaction with naturally occurring antibodies while preserving red cell oxygen carryi ng capacity (abstract). Transfusion 1999; 39(Suppl): S365.Search in Google Scholar
Khuu HM, Marques MB, Huang Z, Annunziata D, Huang ST. Methoxy- and crosslinked polyethylene glycol binding to red cells is stable and does not affect cell membrane function (abstract).Transfusion 1999;39(Suppl):S366.Search in Google Scholar
Garratty G, Leger R, Arndt P, A rm s t rong JK, Meiselman HJ, Fisher TC. Polyethylene glycol treatment of RBCs can mask blood group antigens, but may also cause non-specific protein uptake (abstract). Blood 1997;90(Suppl 1):473a.Search in Google Scholar
Blagodatin VM. On the problem of toxicity of cyanuric chloride. Gig Tr Prof Zabol 1968:12: 35–9.Search in Google Scholar
Galili U.The natural anti-Gal antibody, the B-like antigen, and human red cell aging. Blood Cells 1998;14:205–28.Search in Google Scholar
Ando K, Kikugawa K, Beppu M. Involvement of sia- lylated poly-N-acetyllactosaminyl sugar chains of band 3 glycoprotein on senescent eythrocytes in anti-band 3 autoantibody binding. J Biol Chem 1994;269:19394–8.10.1016/S0021-9258(17)32181-6Search in Google Scholar
Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997;37:357–61.10.1046/j.1537-2995.1997.37497265334.x9111271Search in Google Scholar
King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients’red cells. Transfusion 1997;37(4):376–81.10.1046/j.1537-2995.1997.37497265337.x9111274Search in Google Scholar
Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382–92.10.1046/j.1537-2995.1997.37497265338.x9111275Search in Google Scholar
Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322:1617–21.10.1056/NEJM1990060732223012342522Search in Google Scholar
Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990;76:1431–7.10.1182/blood.V76.7.1431.1431Search in Google Scholar
Norol F, Nadjahi J, Bachir D, et al. Transfusion and alloimmunization in sickle cell anemia patients. Transfus Clin Biol 1994;1:27–34.10.1016/S1246-7820(05)80054-0Search in Google Scholar
Mallory D, Malamut D, Ginther A. Rare blood for patients with sickle cell disease. Ann NY Acad Sci 1989;565:432–3.10.1111/j.1749-6632.1989.tb24214.xSearch in Google Scholar
Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease.Transfusion 1994;34(7):562–9.10.1046/j.1537-2995.1994.34794330008.xSearch in Google Scholar
Sosler SD, Ji lly BJ, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 1993;43:103–6.10.1002/ajh.2830430206Search in Google Scholar
Fisher T C, Arm strong JK, Meiselman HJ. Polyethylene glycol coated RBC vs. hemodilution. Annals Biomed Eng 1997; 25(1):S39.Search in Google Scholar
Jan K, Usami S, Smith JA. Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 1982; 22:17–20.10.1046/j.1537-2995.1982.22182154208.xSearch in Google Scholar
Schmalzer EA, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels: implications for transfu- sion.Transfusion 1987;27:228–33.10.1046/j.1537-2995.1987.27387235626.xSearch in Google Scholar
Armstrong JK, Meiselman HJ, Fisher TC. Poly(ethy- lene glycol)-coated red blood cells in an in vitro model of transfusion therapy in sickle cell disease (abstract). Blood 1998; 92(Suppl 1):671a.Search in Google Scholar
Schmalzer EA, Chien S, Brown AK. Transfusion therapy in sickle cell disease. Am J Ped Hemat Onc 1987;4:395–406.10.1097/00043426-198224000-00007Search in Google Scholar
Blackall D, Carrigan DJ, Armstrong JK, Meiselman HJ, Fisher TC. Polyethylene glycol-coated red-blood-cells fail to bind glycophorin A-specific antibodies and are impervious to invasion by Plasmodium - falciparum malaria parasites (abstract). Transfusion 1998;38 (Suppl):S227.Search in Google Scholar
Ali NM, Diaz-Fuentes G, Rosenberg M, Boctor FN. Exchange transfusion therapy as an adjunct to the treatment of falciparium malaria (abstract). Transfusion 1998;38(Suppl):S162.Search in Google Scholar
Murad KL, Gosselin EJ, Eaton JW, Scott MD. Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 1999;94: 2135–41.10.1182/blood.V94.6.2135Search in Google Scholar
Smith GN, Mollison PL. Responses in rabbits to the red cell alloantigen HgA. Immunology 1974;26: 865–75.Search in Google Scholar
Moise KJ, Rodkey LS, Saade G, et al. An animal model for hemolytic disease of the fetus and newborn. I. Alloimmunization techniques. Am J Obstet Gynecol 1995;173:51–4.10.1016/0002-9378(95)90168-XSearch in Google Scholar
Cohen C. Blood group factors in the rabbit. II.The inheritance of six factors. Genetics 1955;40: 770–80.10.1093/genetics/40.6.770122434617247589Search in Google Scholar
